American International Group, Inc. Avenue Therapeutics, Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$2.41 - $7.11 $9,360 - $27,615	-3,884 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$4.7 - $7.17 $47 - $71	10 Added 0.26%	3,884 $24,000
Q4 2020 Feb 12, 2021	SELL	$2.95 - $11.04 $324 - $1,214	-110 Reduced 2.76%	3,874 $23,000
Q3 2020 Nov 04, 2020	SELL	$9.37 - $12.06 $852 - $1,097	-91 Reduced 2.23%	3,984 $43,000
Q2 2020 Aug 12, 2020	BUY	$8.29 - $11.47 $33,781 - $46,740	4,075 New	4,075 $44,000

Ticker ATXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,127,720
Market Cap $8.5M
Description
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was in...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.